BR112014028239A2 - composições para solubilização de células e/ou tecido - Google Patents

composições para solubilização de células e/ou tecido

Info

Publication number
BR112014028239A2
BR112014028239A2 BR112014028239A BR112014028239A BR112014028239A2 BR 112014028239 A2 BR112014028239 A2 BR 112014028239A2 BR 112014028239 A BR112014028239 A BR 112014028239A BR 112014028239 A BR112014028239 A BR 112014028239A BR 112014028239 A2 BR112014028239 A2 BR 112014028239A2
Authority
BR
Brazil
Prior art keywords
compositions
tissue
cell
solubilization
skin
Prior art date
Application number
BR112014028239A
Other languages
English (en)
Other versions
BR112014028239B1 (pt
Inventor
Hee Hwang Byeong
M Lebovitz Russell
Mitragotri Samir
Original Assignee
Dx Biosciences Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dx Biosciences Inc, Univ California filed Critical Dx Biosciences Inc
Publication of BR112014028239A2 publication Critical patent/BR112014028239A2/pt
Publication of BR112014028239B1 publication Critical patent/BR112014028239B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5422—Polymers characterized by specific structures/properties characterized by the charge nonionic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5428—Polymers characterized by specific structures/properties characterized by the charge amphoteric or zwitterionic

Abstract

resumo patente de invenção: "composições para solubilização de células e/ou tecido". são fornecidas as composições de solubilização. as composições compreendem, pelo menos, um tensoativo zwitteriônico e, pelo menos, um tensoativo não iônico. em uma modalidade, as composições podem ser úteis para solubilização e remodelagem e/ou remoção de tecido sobre ou abaixo da pele de um paciente, opcionalmente juntamente com a aplicação de energia a uma região de interesse da pele. em uma modalidade, pelo menos um analito pode ser coletado e analisado, a partir do tecido solubilizado.
BR112014028239-0A 2012-05-16 2012-05-16 composições e métodos para solubilização, remodelagem e/ou remoção de células e/ou tecido e para recuperar analitos da membrana da mucosa, da pele ou outro tecido BR112014028239B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/038169 WO2013172832A1 (en) 2012-05-16 2012-05-16 Compositions for solubilizing cells and/or tissue

Publications (2)

Publication Number Publication Date
BR112014028239A2 true BR112014028239A2 (pt) 2017-06-27
BR112014028239B1 BR112014028239B1 (pt) 2021-05-11

Family

ID=49584087

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014028239-0A BR112014028239B1 (pt) 2012-05-16 2012-05-16 composições e métodos para solubilização, remodelagem e/ou remoção de células e/ou tecido e para recuperar analitos da membrana da mucosa, da pele ou outro tecido

Country Status (10)

Country Link
EP (2) EP3056559B1 (pt)
JP (1) JP2015528691A (pt)
KR (1) KR102099487B1 (pt)
CN (1) CN104520418A (pt)
AU (2) AU2012380348B2 (pt)
BR (1) BR112014028239B1 (pt)
CA (1) CA2873707A1 (pt)
IN (1) IN2014MN02536A (pt)
MX (1) MX369625B (pt)
WO (1) WO2013172832A1 (pt)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5358492A (en) * 1976-11-08 1978-05-26 Kao Corp Anti-foggig agent composition with lng lasting effect
US5639630A (en) * 1995-05-16 1997-06-17 Bayer Corporation Method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes
ATE229817T1 (de) * 1996-10-24 2003-01-15 Alza Corp Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung
US7776542B1 (en) * 1997-08-04 2010-08-17 Advanced Life Science Institute Methods for the detection of hepatitis B and C viruses
US6589173B1 (en) 2000-07-17 2003-07-08 The Regents Of The University Of California Ultrasound system for disease detection and patient treatment
FR2848848B1 (fr) * 2002-12-19 2005-01-28 Oreal Composition de lavage des matieres keratiniques a base de tensioactif amphotere et de peg modifie par un groupe hydrophobe
US7186522B2 (en) * 2003-03-31 2007-03-06 Cytyc Corporation Papanicolau staining process
WO2005012549A2 (en) * 2003-08-01 2005-02-10 Fqubed, Inc. Apparatus and methods for evaluating the barrier properties of a membrane
US7608278B2 (en) * 2003-12-30 2009-10-27 Wyeth Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability
JP4422550B2 (ja) * 2004-05-25 2010-02-24 日華化学株式会社 親水性フッ素樹脂粒子の製造方法
WO2006026248A1 (en) * 2004-08-25 2006-03-09 Sigma-Aldrich Co. Compositions and methods employing zwitterionic detergent combinations
US8389582B2 (en) * 2007-08-06 2013-03-05 Samir Mitragotri Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether
WO2009048681A2 (en) * 2007-08-06 2009-04-16 The Regents Of The University Of California Methods of tissue-based diagnosis
EP2278997B1 (en) * 2008-04-21 2016-08-10 Nanobio Corporation Nanoemulsion influenza vaccine
AU2009240389A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections
US7700530B2 (en) * 2008-06-30 2010-04-20 Kimberly Clark Worldwide, Inc. Polysensorial personal care cleanser comprising a quaternary silicone surfactant
JP5382687B2 (ja) * 2008-11-12 2014-01-08 独立行政法人産業技術総合研究所 ルシフェリン−ルシフェラーゼ反応における発光強度の低下を抑制するための組成物及び方法
CA2750233A1 (en) * 2009-01-28 2010-08-05 Nanobio Corporation Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
EP2396654B1 (en) * 2009-02-13 2016-02-10 The Regents of The University of California Composition and method for tissue-based diagnosis
US20120064136A1 (en) * 2010-09-10 2012-03-15 Nanobio Corporation Anti-aging and wrinkle treatment methods using nanoemulsion compositions

Also Published As

Publication number Publication date
BR112014028239B1 (pt) 2021-05-11
EP3056559B1 (en) 2019-07-10
CN104520418A (zh) 2015-04-15
CA2873707A1 (en) 2013-11-21
MX369625B (es) 2019-11-14
AU2017203389A1 (en) 2017-06-08
EP3056559A3 (en) 2016-10-12
KR102099487B1 (ko) 2020-04-09
KR20150023394A (ko) 2015-03-05
AU2012380348B2 (en) 2017-02-23
WO2013172832A1 (en) 2013-11-21
AU2012380348A1 (en) 2015-01-22
EP2756061A4 (en) 2014-08-13
MX2014013794A (es) 2015-04-08
IN2014MN02536A (pt) 2015-09-04
EP3056559A2 (en) 2016-08-17
JP2015528691A (ja) 2015-10-01
EP2756061A1 (en) 2014-07-23

Similar Documents

Publication Publication Date Title
CL2017003218A1 (es) Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi)
CL2014003121A1 (es) Formulacion liquida que comprende propilenglicol y un inodilatador, un inhibidor de la enzima convertidora de angiotensina o una combinacion de ambos; proceso para prepararla; kit; y metodo de tratamiento de una enfermedad cardiaca y/o hipertension.
AR090339A1 (es) Metodos de pronostico, diagnostico y tratamiento de la fibrosis pulmonar idiopatica
UY33802A (es) Composiciones inmunógenas que comprenden un antígeno relacionado con M72 y que tienen una fuerza iónica baja
DK2375907T3 (da) Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller
BR112013014242A2 (pt) composto da fórmula, composição farmacêutica, método de tratamento de doença de gaucher e método de aumento da quantidade de beta glicocerebrosidase nas células sanguíneas brancas
BR112013004914A2 (pt) "composições de pele e métodos de uso das mesmas".
BRPI0912292A2 (pt) composições e métodos para o uso de células no tratamento do tecido cardíaco.
BRPI0722043A2 (pt) composições de clareamento de pele cosmética tópicas e métodos de uso das mesmas.
WO2011007183A3 (en) Skin care composition for the treatment of acne vulgaris
MX2014009256A (es) Dispositivos de recogida de muestras con agentes de estabilizacion sanguinea.
BR112014009837A8 (pt) uso eficaz da levedura e extrato de levedura
BR112015011404A2 (pt) ferramenta de laser cirúrgico
DK2407151T3 (da) Sammensætning til behandling af hud- og/eller neglelæsioner
ATE546147T1 (de) Zusammensetzungen und verfahren zur behandlung und vorbeugung von kardiomyopathie und herzerkrankung
BR112014003071A2 (pt) tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical
WO2013126590A8 (en) Pharmaceutical composition comprising cd34+ cells
BR112013003471A2 (pt) solução de testosterona, e, método para tratar deficiência de testosterona
BR112015019395A2 (pt) composições e métodos para tratar e reparar tendões
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
BR112015015341A2 (pt) composições para permeabilização de células sanguíneas fixadas e usos das mesmas
BR112014012858A2 (pt) extrato de jojoba útil em melhorar as funções de barreira da pele
FR2969924B1 (fr) Composition comprenant un phosphate de tocopherol
MX2011011559A (es) Parasiticidas sanguineos.
BR112014028239A2 (pt) composições para solubilização de células e/ou tecido

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C11D 1/88 , C07K 1/14

Ipc: A61K 8/46 (2006.01), A61K 8/86 (2006.01), A61Q 19/

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/05/2012, OBSERVADAS AS CONDICOES LEGAIS.